Sphera Funds Management Ltd.
- SEC CIK
- 0001496201
- 最新申報
- 2026/8/14
2021 年第 3 季持倉
持倉截至 2021/9/30，2021/11/15 申報。只含多頭部位，變化是跟 2021 年第 2 季比股數。
- 持股檔數
- 107
- 較 2021 年第 2 季 −14
- 總值
- $10.1 億
- 較 2021 年第 2 季 −$4,147 萬 (−3.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| LLYEli Lilly & Co | Stock | 348,495 | $8,052 萬 | 8.0% | +166,600+91.6% | 加碼 | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 1,291,667 | $7,758 萬 | 7.7% | +143,994+12.5% | 加碼 | 歷史 |
| ABBVAbbVie Inc. | Stock | 596,294 | $6,432 萬 | 6.4% | +230,100+62.8% | 加碼 | 歷史 |
| PFEPfizer Inc | Stock | 1,106,528 | $4,759 萬 | 4.7% | +1,106,528 | 新進 | 歷史 |
| SNYSanofi | SPONSORED ADR | 843,400 | $4,066 萬 | 4.0% | 00.0% | 不變 | 歷史 |
| JNJJohnson & Johnson | Stock | 238,948 | $3,859 萬 | 3.8% | −166,660−41.1% | 減碼 | 歷史 |
| GNRCGenerac Holdings Inc. | Stock | 71,013 | $2,902 萬 | 2.9% | −33,350−32.0% | 減碼 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 359,260 | $2,110 萬 | 2.1% | +99,365+38.2% | 加碼 | 歷史 |
| MSFTMicrosoft Corp | Stock | 67,536 | $1,904 萬 | 1.9% | 00.0% | 不變 | 歷史 |
| CCCCC4 Therapeutics, Inc. | COM STK | 381,774 | $1,706 萬 | 1.7% | −136,837−26.4% | 減碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 247,917 | $1,573 萬 | 1.6% | +52,800+27.1% | 加碼 | 歷史 |
| ZLABZai Lab Ltd | ADR | 145,982 | $1,539 萬 | 1.5% | +48,036+49.0% | 加碼 | 歷史 |
| PANWPalo Alto Networks Inc | Stock | 31,000 | $1,485 萬 | 1.5% | +31,000 | 新進 | 歷史 |
| KURAKura Oncology, Inc. | COM | 788,735 | $1,477 萬 | 1.5% | −80,151−9.2% | 減碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 750,603 | $1,434 萬 | 1.4% | +203,416+37.2% | 加碼 | 歷史 |
| SEDGSolaredge Technologies, Inc. | COM | 50,000 | $1,326 萬 | 1.3% | +17,800+55.3% | 加碼 | 歷史 |
| FATEFate Therapeutics Inc | COM | 219,299 | $1,300 萬 | 1.3% | +54,000+32.7% | 加碼 | 歷史 |
| ALTAltimmune, Inc. | COM NEW | 1,088,854 | $1,232 萬 | 1.2% | +405,459+59.3% | 加碼 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 494,809 | $1,220 萬 | 1.2% | +116,167+30.7% | 加碼 | 歷史 |
| HOWLWerewolf Therapeutics, Inc. | COM | 688,475 | $1,181 萬 | 1.2% | −17,819−2.5% | 減碼 | 歷史 |
| METAMeta Platforms, Inc. | Stock | 34,400 | $1,168 萬 | 1.2% | +7,400+27.4% | 加碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 548,643 | $1,155 萬 | 1.1% | −85,445−13.5% | 減碼 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 149,017 | $1,152 萬 | 1.1% | +149,017 | 新進 | 歷史 |
| TWLOTwilio Inc | CL A | 35,500 | $1,133 萬 | 1.1% | +9,000+34.0% | 加碼 | 歷史 |
| NICENICE Ltd. | SPONSORED ADR | 37,786 | $1,073 萬 | 1.1% | −39,000−50.8% | 減碼 | 歷史 |
| Wix.com Ltd.92940WAD1 | NOTE 8/1 | 11,100,000 | $1,072 萬 | 1.1% | +11,100,000 | 新進 | – |
| VINCVincerx Pharma, Inc. | COM NEW | 654,572 | $1,058 萬 | 1.0% | +427,122+187.8% | 加碼 | 歷史 |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 3,824,938 | $1,048 萬 | 1.0% | −255,735−6.3% | 減碼 | 歷史 |
| KRNTKornit Digital Ltd. | SHS | 72,076 | $1,043 萬 | 1.0% | −75,717−51.2% | 減碼 | 歷史 |
| IMTXImmatics N.V. | SHS | 800,043 | $1,040 萬 | 1.0% | +800,043 | 新進 | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 310,077 | $1,033 萬 | 1.0% | +120,994+64.0% | 加碼 | 歷史 |
| AUDCAudiocodes Ltd | ORD | 316,428 | $1,030 萬 | 1.0% | −68,766−17.9% | 減碼 | 歷史 |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 1,000,000 | $1,006 萬 | 1.0% | +500,000+100.0% | 加碼 | 歷史 |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 527,948 | $995.2 萬 | 1.0% | +527,948 | 新進 | 歷史 |
| ALXOAlx Oncology Holdings Inc | COM | 128,706 | $950.6 萬 | 0.9% | −64,022−33.2% | 減碼 | 歷史 |
| NKENIKE, Inc. | Stock | 65,000 | $944.0 萬 | 0.9% | +65,000 | 新進 | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 531,269 | $870.7 萬 | 0.9% | +506,312+2,028.7% | 加碼 | 歷史 |
| RUNSunrun Inc. | COM | 189,000 | $831.6 萬 | 0.8% | +117,000+162.5% | 加碼 | 歷史 |
| ONCROncorus, Inc. | COM | 880,702 | $822.6 萬 | 0.8% | −12,846−1.4% | 減碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 832,878 | $811.2 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| CSTECaesarstone Ltd. | ORD SHS | 644,146 | $800.0 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 485,001 | $787.6 萬 | 0.8% | −14,999−3.0% | 減碼 | 歷史 |
| ADSKAutodesk, Inc. | COM | 27,500 | $784.2 萬 | 0.8% | +27,500 | 新進 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 294,619 | $751.0 萬 | 0.7% | −40,175−12.0% | 減碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 130,330 | $703.7 萬 | 0.7% | +130,330 | 新進 | 歷史 |
| Affimed N VN01045108 | COM | 1,117,619 | $690.7 萬 | 0.7% | −159,083−12.5% | 減碼 | – |
| BCLS Acquisition CorpG0904B105 | COM CL A | 687,900 | $687.9 萬 | 0.7% | 00.0% | 不變 | – |
| MRUSMerus N.V. | COM | 309,427 | $680.7 萬 | 0.7% | +22,921+8.0% | 加碼 | 歷史 |
| VRNTVerint Systems Inc | COM | 150,000 | $671.9 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| TEADTeads Holding Co. | COM | 431,194 | $638.2 萬 | 0.6% | +431,194 | 新進 | 歷史 |
| BCABBioAtla, Inc. | COM | 214,300 | $630.9 萬 | 0.6% | +214,300 | 新進 | 歷史 |
| ZENZendesk, Inc. | COM | 53,910 | $627.5 萬 | 0.6% | +53,910 | 新進 | 歷史 |
| RACBResearch Alliance Corp. II | COM CL A | 600,000 | $591.0 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 373,510 | $570.7 萬 | 0.6% | +97,380+35.3% | 加碼 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 739,190 | $568.4 萬 | 0.6% | +739,190 | 新進 | 歷史 |
| PMVPPMV Pharmaceuticals, Inc. | COM | 190,525 | $567.8 萬 | 0.6% | +106,451+126.6% | 加碼 | 歷史 |
| STROSutro Biopharma, Inc. | COM | 294,825 | $556.9 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| QUREuniQure N.V. | SHS | 172,000 | $550.6 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| CALXCalix, Inc | COM | 105,290 | $520.4 萬 | 0.5% | +105,290 | 新進 | 歷史 |
| ALLTAllot Ltd. | SHS | 341,067 | $506.8 萬 | 0.5% | +64,880+23.5% | 加碼 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 800,000 | $491.2 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| CRBUCaribou Biosciences, Inc. | COM | 200,000 | $477.4 萬 | 0.5% | +200,000 | 新進 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 491,159 | $469.1 萬 | 0.5% | +491,159 | 新進 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 260,379 | $461.4 萬 | 0.5% | −42,586−14.1% | 減碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 801,256 | $439.1 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| Ironsource LtdM5R75Y101 | CL A ORD SHS | 367,070 | $399.0 萬 | 0.4% | +367,070 | 新進 | – |
| ALGSAligos Therapeutics, Inc. | COM | 249,197 | $386.5 萬 | 0.4% | +249,197 | 新進 | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 198,880 | $382.0 萬 | 0.4% | +198,880 | 新進 | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 469,402 | $375.5 萬 | 0.4% | −178,901−27.6% | 減碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 225,083 | $365.5 萬 | 0.4% | −144,631−39.1% | 減碼 | 歷史 |
| IMUXImmunic, Inc. | COM | 389,812 | $345.0 萬 | 0.3% | +389,812 | 新進 | 歷史 |
| Eucrates Biomedical Acqu CorG3141W106 | SHS | 329,025 | $321.8 萬 | 0.3% | 00.0% | 不變 | – |
| NTLAIntellia Therapeutics, Inc. | COM | 23,647 | $317.2 萬 | 0.3% | −28,903−55.0% | 減碼 | 歷史 |
| LESLLeslie's, Inc. | COM | 150,000 | $308.1 萬 | 0.3% | +150,000 | 新進 | 歷史 |
| OTMOOtonomo Technologies Ltd. | ORDINARY SHARES | 600,000 | $286.8 萬 | 0.3% | +600,000 | 新進 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 9,249 | $279.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| DICEDICE Therapeutics, Inc. | COM | 85,000 | $278.4 萬 | 0.3% | +85,000 | 新進 | 歷史 |
| Bio Green Med Solution, Inc.23254L603 | COM | 508,322 | $267.9 萬 | 0.3% | 00.0% | 不變 | – |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 119,647 | $266.6 萬 | 0.3% | +19,647+19.6% | 加碼 | 歷史 |
| HIPOHippo Holdings Inc. | COMMON STOCK | 564,967 | $264.4 萬 | 0.3% | +564,967 | 新進 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 100,391 | $263.4 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CVRXCVRx, Inc. | COM | 150,000 | $248.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CYTCyteir Therapeutics, Inc. | COM | 135,145 | $237.2 萬 | 0.2% | +10,145+8.1% | 加碼 | 歷史 |
| ANNXAnnexon, Inc. | COM | 123,637 | $230.1 萬 | 0.2% | −24,681−16.6% | 減碼 | 歷史 |
| Turmeric Acquisition CorpG9127T108 | CL A | 219,440 | $214.8 萬 | 0.2% | 00.0% | 不變 | – |
| ARYEARYA Sciences Acquisition Corp V | CLASS A ORD SHS | 200,000 | $197.6 萬 | 0.2% | +200,000 | 新進 | 歷史 |
| JYACJiya Acquisition Corp. | COM CL A | 199,028 | $194.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 242,500 | $188.9 萬 | 0.2% | −49,694−17.0% | 減碼 | – |
| AMATApplied Materials Inc | Stock | 14,500 | $186.7 萬 | 0.2% | +14,500 | 新進 | 歷史 |
| MOLNMolecular Partners AG | ADS | 80,555 | $158.0 萬 | 0.2% | +80,555 | 新進 | 歷史 |
| ERASErasca, Inc. | COM | 70,000 | $148.5 萬 | 0.1% | +70,000 | 新進 | 歷史 |
| LVTXLAVA Therapeutics NV | SHS | 215,359 | $127.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FLACFrazier Lifesciences Acquisition Corp | CL A SHS | 126,687 | $124.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Magic Software Enterprises L559166103 | ORD | 57,704 | $115.4 萬 | 0.1% | +41,728+261.2% | 加碼 | – |
| Omega Alpha SpacG6749V107 | CL A | 100,000 | $97.4 萬 | 0.1% | 00.0% | 不變 | – |
| Nice Sys Inc65366HAB9 | NOTE 1.250% 1/1 | 250,000 | $84.6 萬 | 0.1% | 00.0% | 不變 | – |
| ACIUAC Immune SA | SHS | 121,019 | $81.2 萬 | 0.1% | +121,019 | 新進 | 歷史 |
| KAKineta, Inc. | COM | 75,836 | $78.3 萬 | 0.1% | −39,462−34.2% | 減碼 | 歷史 |
| CM Life Sciences III Inc125841205 | UNIT 04/30/2028 | 75,000 | $76.9 萬 | 0.1% | 00.0% | 不變 | – |
| IONSIonis Pharmaceuticals Inc | COM | 22,000 | $73.8 萬 | 0.1% | +22,000 | 新進 | 歷史 |
選擇權（9 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $5,028 萬 | – |
| iShares Russell 2000 ETF464287655 | ETF | $4,594 萬 | – |
| BMYBristol Myers Squibb Co | Stock | – | $2,959 萬 |
| BIIBBiogen Inc. | COM | – | $1,415 萬 |
| IONSIonis Pharmaceuticals Inc | COM | – | $1,174 萬 |
| ALTAltimmune, Inc. | COM NEW | – | $1,131 萬 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | – | $1,023 萬 |
| PTGXProtagonist Therapeutics, Inc | COM | – | $443.0 萬 |
| QUREuniQure N.V. | SHS | – | $320.1 萬 |
2021 年第 2 季之後清倉（47 檔）
2021 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 2 季股數 | 2021 年第 2 季市值 | 2021 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| MRKMerck & Co., Inc. | Stock | 772,601 | $6,009 萬 | 5.7% | 歷史 |
| LPSNLiveperson Inc | COM | 225,000 | $1,423 萬 | 1.4% | 歷史 |
| VRNSVaronis Systems Inc | COM | 218,013 | $1,256 萬 | 1.2% | 歷史 |
| Therapeutics Acquisition Cor88339T103 | COM CL A | 1,009,497 | $1,038 萬 | 1.0% | – |
| BIIBBiogen Inc. | COM | 23,995 | $830.9 萬 | 0.8% | 歷史 |
| NKTXNkarta, Inc. | COM | 252,478 | $800.1 萬 | 0.8% | 歷史 |
| STTKShattuck Labs, Inc. | COM | 274,214 | $794.9 萬 | 0.8% | 歷史 |
| ONTOOnto Innovation Inc. | COM | 107,548 | $785.5 萬 | 0.7% | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 233,135 | $784.7 萬 | 0.7% | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 47,309 | $764.2 萬 | 0.7% | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 20,900 | $717.3 萬 | 0.7% | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 244,157 | $647.7 萬 | 0.6% | 歷史 |
| ORTXOrchard Therapeutics plc | ADS | 1,366,564 | $599.9 萬 | 0.6% | 歷史 |
| ATERAterian, Inc. | Equity | 399,999 | $585.2 萬 | 0.6% | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 173,891 | $537.1 萬 | 0.5% | 歷史 |
| FVRRFiverr International Ltd. | ORD SHS | 21,500 | $521.4 萬 | 0.5% | 歷史 |
| CRISCuris Inc | COM NEW | 588,264 | $474.7 萬 | 0.5% | 歷史 |
| NBPNovaBridge Biosciences | SPONSORED ADS | 46,350 | $389.1 萬 | 0.4% | 歷史 |
| SGTXSigilon Therapeutics, Inc. | COM | 360,239 | $386.5 萬 | 0.4% | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 28,425 | $365.9 萬 | 0.3% | 歷史 |
| PLTKPlaytika Holding Corp. | COM | 150,000 | $357.6 萬 | 0.3% | 歷史 |
| ARKOARKO Corp. | COM | 369,875 | $339.9 萬 | 0.3% | 歷史 |
| Gracell Biotechnologies Inc38406L103 | SPONSORED ADS | 233,850 | $304.0 萬 | 0.3% | – |
| NEXNNexxen International Ltd. | ADS | 150,000 | $298.5 萬 | 0.3% | 歷史 |
| SSentinelOne, Inc. | CL A | 68,400 | $290.7 萬 | 0.3% | 歷史 |
| KRROKorro Bio, Inc. | COM | 275,160 | $274.1 萬 | 0.3% | 歷史 |
| PRGOPERRIGO Co plc | SHS | 52,500 | $240.7 萬 | 0.2% | 歷史 |
| TWSTTwist Bioscience Corp | COM | 18,000 | $239.9 萬 | 0.2% | 歷史 |
| Cerevel Therapeutics HLDNG I15678U102 | *W EXP 06/09/202 | 165,295 | $237.9 萬 | 0.2% | – |
| IPSCCentury Therapeutics, Inc. | COM | 80,000 | $234.7 萬 | 0.2% | 歷史 |
| HYPRHyperfine, Inc. | CL A SHS | 200,000 | $197.0 萬 | 0.2% | 歷史 |
| Healthcare Capital Corp42228C200 | UNIT 12/31/2025 | 196,610 | $196.2 萬 | 0.2% | – |
| ALDXAldeyra Therapeutics, Inc. | COM | 150,000 | $170.0 萬 | 0.2% | 歷史 |
| WIXWix.com Ltd. | SHS | 5,700 | $165.5 萬 | 0.2% | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 51,000 | $148.5 萬 | 0.1% | 歷史 |
| OMICSingular Genomics Systems, Inc. | COM | 53,867 | $148.0 萬 | 0.1% | 歷史 |
| Clarim Acquisition Corp18049C207 | UNIT 99/99/9999 | 148,886 | $147.8 萬 | 0.1% | – |
| PRAXPraxis Precision Medicines, Inc. | COM | 75,600 | $138.2 萬 | 0.1% | 歷史 |
| DFPHStarling Oncology, Inc. | COM CL A | 126,491 | $125.7 萬 | 0.1% | 歷史 |
| Lefteris Acquisition Corp52470X109 | COM CL A | 114,428 | $111.6 萬 | 0.1% | – |
| CELCCelcuity Inc. | COM | 45,000 | $108.0 萬 | 0.1% | 歷史 |
| MSPRMSP Recovery, Inc. | COM CL A | 99,859 | $98.6 萬 | 0.1% | 歷史 |
| E Merge Technology Acquisiti26873Y104 | COM CL A | 100,000 | $97.6 萬 | 0.1% | – |
| Apollo Strategic Growth CaptG0411R106 | SHS CL A | 73,055 | $71.4 萬 | 0.1% | – |
| Tailwind Internatnal Acq CorG8662F127 | UNIT 99/99/9999 | 48,342 | $48.3 萬 | <0.1% | – |
| ELEVElevation Acquisition Group Inc. | COM | 30,000 | $40.7 萬 | <0.1% | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 9,212 | $23.6 萬 | <0.1% | 歷史 |